Search Results - "Vonderhaar, Emily P."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models by Jing, Weiqing, McAllister, Donna, Vonderhaar, Emily P, Palen, Katie, Riese, Matthew J, Gershan, Jill, Johnson, Bryon D, Dwinell, Michael B

    Published in Journal for immunotherapy of cancer (29-04-2019)
    “…Pancreatic cancer is characterized by an immune suppressive stromal reaction that creates a barrier to therapy. A murine transgenic pancreatic cancer cell line…”
    Get full text
    Journal Article
  2. 2

    Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches by Vonderhaar, Emily P, Dwinell, Michael B, Craig, Brian T

    Published in Frontiers in immunology (22-06-2023)
    “…Surgery or radiation therapy is nearly universally applied for pediatric solid tumors. In many cases, in diverse tumor types, distant metastatic disease is…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma by Roy, Ishan, Boyle, Kathleen A, Vonderhaar, Emily P, Zimmerman, Noah P, Gorse, Egal, Mackinnon, A Craig, Hwang, Rosa F, Franco-Barraza, Janusz, Cukierman, Edna, Tsai, Susan, Evans, Douglas B, Dwinell, Michael B

    Published in Laboratory investigation (01-03-2017)
    “…The mechanisms by which the extreme desmoplasia observed in pancreatic tumors develops remain unknown and its role in pancreatic cancer progression is…”
    Get full text
    Journal Article
  5. 5

    Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection by Lange, Philip T, Darrah, Eric J, Vonderhaar, Emily P, Mboko, Wadzanai P, Rekow, Michaela M, Patel, Shailendra B, Sidjanin, Duska J, Tarakanova, Vera L

    Published in Journal of virology (01-04-2016)
    “…The cholesterol synthesis pathway is a ubiquitous cellular biosynthetic pathway that is attenuated therapeutically by statins. Importantly, type I interferon…”
    Get full text
    Journal Article
  6. 6